Monday, April 22, 2024 12:32:32 PM
ILT,
How could we not know the combo is working? For me, it is definitive it is is working amazingly. There are no theoretical conversations. What we need is just some logical and commonsense reasoning.
Take the colorectal cancer trial as an example. There are no data at all. But what we do see is that the research focus of immunotherapy institute at Mainz has been completely focusing on dendritic cell related stuff. They bought the instruments for protemoic analysis. There is also dramatic increase in publications on dendrtic cell. The CEO of BioNTech at Germany was a professor from Mainz. He still is now probably. BioNtech was supposed to start its trial at UK about its mRNA cancer vaccine in 2026. Boy, BioNtech was in such a big hurry and started last December. Does the company get a lion chasing them?
I don't need to mention about glioblastoma.
I saw in the latest Moonshot presentation. Two cancer programs were specifically mentioned: colorectal cancer and brain tumor. Is it coincidence?
IMO, if it is a sure thing in biotech, then we as retailers can only have leftover.
You don't have a X account? I am so poor that I cannot afford ihub membership.
How could we not know the combo is working? For me, it is definitive it is is working amazingly. There are no theoretical conversations. What we need is just some logical and commonsense reasoning.
Take the colorectal cancer trial as an example. There are no data at all. But what we do see is that the research focus of immunotherapy institute at Mainz has been completely focusing on dendritic cell related stuff. They bought the instruments for protemoic analysis. There is also dramatic increase in publications on dendrtic cell. The CEO of BioNTech at Germany was a professor from Mainz. He still is now probably. BioNtech was supposed to start its trial at UK about its mRNA cancer vaccine in 2026. Boy, BioNtech was in such a big hurry and started last December. Does the company get a lion chasing them?
I don't need to mention about glioblastoma.
I saw in the latest Moonshot presentation. Two cancer programs were specifically mentioned: colorectal cancer and brain tumor. Is it coincidence?
IMO, if it is a sure thing in biotech, then we as retailers can only have leftover.
You don't have a X account? I am so poor that I cannot afford ihub membership.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
